The Canadian Optimal Therapy of COPD Trial: Design, Organization and Patient Recruitment

BACKGROUND: There are no published studies that have assessed whether adding long-acting beta 2-agonist bronchodilators and/or inhaled steroids to chronic therapy with tiotropium would provide additional clinical benefit to patients with moderate to severe chronic obstructive pulmonary disease (COPD...

Full description

Saved in:
Bibliographic Details
Main Authors: Shawn D Aaron, Katherine Vandemheen, Dean Fergusson, Mark FitzGerald, Francois Maltais, Jean Bourbeau, Roger Goldstein, Andrew McIvor, Meyer Balter, Denis O'Donnell
Format: Article
Language:English
Published: Wiley 2004-01-01
Series:Canadian Respiratory Journal
Online Access:http://dx.doi.org/10.1155/2004/394710
Tags: Add Tag
No Tags, Be the first to tag this record!

Similar Items